Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-24 @ 7:35 PM
NCT ID:
NCT02670603
Eligibility Criteria:
Inclusion Criteria:
* Patients with breast cancer receiving adjuvant/neoadjuvant docetaxel chemotherapy
Exclusion Criteria:
* Patients with breast cancer receiving palliative docetaxel chemotherapy
* Patients having onycholysis before docetaxel treatment
Healthy Volunteers:
True
Sex:
FEMALE
Study:
NCT02670603
Study Brief:
Protocol Section:
NCT02670603